2021 |
02/18 | 4,550 | 4,565 | 4,495 | 4,529 | +0.53% | 756,600 | 2兆5264億 | +0.15% |
02/17 | 4,533 | 4,535 | 4,486 | 4,505 | -0.4% | 629,400 | 2兆5130億 | -0.24% |
02/16 | 4,529 | 4,555 | 4,498 | 4,523 | -0.15% | 881,000 | 2兆5230億 | +0.24% |
02/15 | 4,600 | 4,615 | 4,482 | 4,530 | -1.24% | 862,300 | 2兆5269億 | +0.51% |
02/12 | 13:30 公認会計士等の異動に関するお知らせ |
02/12 | 13:30 個別業績の前期実績との差異に関するお知らせ |
02/12 | 13:30 2020年12月期決算短信〔IFRS〕(連結) |
02/12 | 4,697 | 4,697 | 4,556 | 4,587 | -1.84% | 1,082,500 | 2兆5587億 | +1.96% |
02/10 | 4,708 | 4,724 | 4,633 | 4,673 | +0.28% | 810,600 | 2兆6067億 | +4.1% |
02/09 | 4,740 | 4,740 | 4,633 | 4,660 | -1.75% | 765,800 | 2兆5995億 | +4.2% |
02/08 | 4,694 | 4,747 | 4,663 | 4,743 | +1.19% | 934,700 | 2兆6458億 | +6.37% |
02/05 | 4,600 | 4,693 | 4,592 | 4,687 | +2.88% | 913,800 | 2兆6145億 | +5.42% |
02/04 | 4,494 | 4,569 | 4,493 | 4,556 | +0.98% | 767,400 | 2兆5414億 | +2.66% |
02/03 | 4,457 | 4,515 | 4,440 | 4,512 | +1.05% | 595,600 | 2兆5169億 | +1.74% |
02/02 | 4,470 | 4,480 | 4,437 | 4,465 | -1.22% | 630,400 | 2兆4907億 | +0.72% |
02/01 | 4,479 | 4,526 | 4,440 | 4,520 | +1.3% | 619,200 | 2兆5214億 | +1.96% |
01/29 | 4,499 | 4,531 | 4,458 | 4,462 | -1.31% | 842,400 | 2兆4890億 | +0.7% |
01/28 | 4,498 | 4,528 | 4,447 | 4,521 | -0.51% | 1,326,900 | 2兆5219億 | +2.05% |
01/27 | 4,550 | 4,589 | 4,533 | 4,544 | +1.02% | 885,400 | 2兆5348億 | +2.6% |
01/26 | 4,473 | 4,498 | 4,452 | 4,498 | +0.45% | 500,800 | 2兆5091億 | +1.63% |
01/25 | 4,458 | 4,502 | 4,427 | 4,478 | +1.47% | 556,500 | 2兆4979億 | +1.24% |
01/22 | 4,400 | 4,427 | 4,374 | 4,413 | -1.14% | 567,900 | 2兆4617億 | -0.16% |
01/21 | 4,467 | 4,558 | 4,459 | 4,464 | -0.09% | 814,800 | 2兆4901億 | +0.97% |
01/20 | 4,457 | 4,477 | 4,427 | 4,468 | +0.25% | 606,300 | 2兆4924億 | +1.06% |
01/19 | 4,429 | 4,478 | 4,397 | 4,457 | +0.84% | 544,500 | 2兆4862億 | +0.84% |
01/18 | 4,412 | 4,430 | 4,392 | 4,420 | +0.14% | 486,600 | 2兆4656億 | +0.07% |
01/15 | 4,394 | 4,434 | 4,369 | 4,414 | -0.16% | 637,500 | 2兆4622億 | -0.07% |
01/14 | 4,367 | 4,445 | 4,355 | 4,421 | +0.89% | 853,300 | 2兆4661億 | +0.18% |
01/13 | 4,374 | 4,392 | 4,321 | 4,382 | -0.45% | 842,200 | 2兆4444億 | -0.68% |
01/12 | 4,363 | 4,417 | 4,335 | 4,402 | -0.07% | 717,900 | 2兆4555億 | -0.23% |
01/08 | 4,341 | 4,411 | 4,314 | 4,405 | +1.92% | 986,800 | 2兆4572億 | -0.09% |
01/07 | 4,377 | 4,393 | 4,304 | 4,322 | -0.16% | 1,247,500 | 2兆4109億 | -1.91% |
01/06 | 4,279 | 4,334 | 4,260 | 4,329 | +1.41% | 545,800 | 2兆4148億 | -1.73% |
01/05 | 4,344 | 4,357 | 4,261 | 4,269 | -1.11% | 577,500 | 2兆3814億 | -3% |
01/04 | 4,402 | 4,404 | 4,300 | 4,317 | -2.29% | 522,900 | 2兆4081億 | -2.02% |
2020 |
12/30 | 4,493 | 4,493 | 4,418 | 4,418 | -1.71% | 555,400 | 2兆4645億 | +0.2% |
12/29 | 4,417 | 4,497 | 4,404 | 4,495 | +0.47% | 855,900 | 2兆5074億 | +1.95% |
12/28 | 4,502 | 4,522 | 4,461 | 4,474 | +0.04% | 904,200 | 2兆4957億 | +1.57% |
12/25 | 4,496 | 4,502 | 4,468 | 4,472 | +0.25% | 492,400 | 2兆4946億 | +1.66% |
12/24 | 4,465 | 4,489 | 4,455 | 4,461 | 0% | 463,500 | 2兆4885億 | +1.55% |
12/23 | 4,481 | 4,485 | 4,450 | 4,461 | +0.41% | 542,600 | 2兆4885億 | +1.71% |
12/22 | 4,457 | 4,495 | 4,439 | 4,443 | -1.27% | 673,900 | 2兆4784億 | +1.44% |
12/21 | 4,491 | 4,500 | 4,444 | 4,500 | +0.47% | 591,000 | 2兆5102億 | +2.93% |
12/18 | 4,405 | 4,485 | 4,404 | 4,479 | +1.52% | 1,033,900 | 2兆4985億 | +2.68% |
12/17 | 4,400 | 4,444 | 4,389 | 4,412 | +0.11% | 565,000 | 2兆4611億 | +1.24% |
12/16 | 4,461 | 4,477 | 4,403 | 4,407 | -0.38% | 713,600 | 2兆4583億 | +1.19% |
12/15 | 4,489 | 4,499 | 4,415 | 4,424 | -1.23% | 599,800 | 2兆4678億 | +1.68% |
12/14 | 4,448 | 4,512 | 4,440 | 4,479 | +1.22% | 798,100 | 2兆4985億 | +3.16% |
12/11 | 4,402 | 4,437 | 4,382 | 4,425 | +0.55% | 955,900 | 2兆4684億 | +2.19% |
12/10 | 15:00 超音波腎デナベーションシステム治療抵抗性高血圧に対する2つの国際共同臨床試験結果および米国FDAによるブレークスルーデバイス指定について |
12/10 | 4,385 | 4,406 | 4,372 | 4,401 | -0.16% | 713,800 | 2兆4550億 | +1.88% |
12/09 | 4,350 | 4,414 | 4,335 | 4,408 | +1.8% | 763,500 | 2兆4589億 | +2.32% |
12/08 | 4,355 | 4,355 | 4,319 | 4,330 | -1.52% | 657,200 | 2兆4154億 | +0.91% |
12/07 | 4,406 | 4,422 | 4,377 | 4,397 | +0.66% | 459,200 | 2兆4528億 | +2.93% |
12/04 | 4,358 | 4,402 | 4,349 | 4,368 | +0.69% | 667,000 | 2兆4366億 | +2.63% |
12/03 | 4,303 | 4,370 | 4,297 | 4,338 | +0.35% | 795,200 | 2兆4198億 | +2.26% |
12/02 | 4,297 | 4,336 | 4,278 | 4,323 | +0.7% | 1,058,600 | 2兆4115億 | +2.2% |
12/01 | 4,312 | 4,318 | 4,227 | 4,293 | +1.2% | 1,056,000 | 2兆3947億 | +1.75% |
11/30 | 4,393 | 4,401 | 4,196 | 4,242 | -3.42% | 2,205,400 | 2兆3663億 | +0.76% |
11/27 | 4,393 | 4,418 | 4,346 | 4,392 | 0% | 1,274,100 | 2兆4500億 | +4.52% |
11/26 | 4,370 | 4,392 | 4,331 | 4,392 | -0.25% | 918,700 | 2兆4500億 | +4.77% |
11/25 | 4,444 | 4,447 | 4,400 | 4,403 | +0.18% | 932,600 | 2兆4561億 | +5.33% |
11/24 | 4,367 | 4,443 | 4,357 | 4,395 | +1.62% | 1,146,300 | 2兆4516億 | +5.4% |
11/20 | 4,284 | 4,325 | 4,280 | 4,325 | +0.05% | 659,200 | 2兆4126億 | +4.07% |
11/19 | 4,264 | 4,323 | 4,244 | 4,323 | +0.65% | 1,025,600 | 2兆4115億 | +4.27% |
11/18 | 4,350 | 4,358 | 4,265 | 4,295 | -0.21% | 1,021,600 | 2兆3959億 | +3.74% |
11/17 | 4,260 | 4,324 | 4,237 | 4,304 | +1.68% | 1,214,500 | 2兆4009億 | +4.06% |
11/16 | 4,244 | 4,280 | 4,209 | 4,233 | -0.91% | 1,333,300 | 2兆3613億 | +2.42% |
11/13 | 13:00 2020年12月期第3四半期決算短信〔IFRS〕(連結) |
11/13 | 4,338 | 4,366 | 4,255 | 4,272 | -2.47% | 1,248,400 | 2兆3830億 | +3.36% |
11/12 | 4,336 | 4,396 | 4,318 | 4,380 | +0.99% | 1,264,600 | 2兆4433億 | +5.93% |
11/11 | 4,398 | 4,402 | 4,325 | 4,337 | +0.93% | 1,165,200 | 2兆4193億 | +4.96% |
11/10 | 4,323 | 4,346 | 4,262 | 4,297 | +2.43% | 1,201,500 | 2兆3970億 | +3.97% |
11/09 | 4,205 | 4,211 | 4,171 | 4,195 | +0.31% | 832,200 | 2兆3401億 | +1.48% |
11/06 | 4,120 | 4,192 | 4,097 | 4,182 | -0.12% | 841,000 | 2兆3328億 | +1.06% |
11/05 | 4,139 | 4,197 | 4,101 | 4,187 | +2.37% | 1,228,800 | 2兆3356億 | +0.94% |
11/04 | 4,091 | 4,114 | 4,028 | 4,090 | +2.51% | 1,050,400 | 2兆2815億 | -1.8% |
11/02 | 3,919 | 4,004 | 3,918 | 3,990 | +3.5% | 768,100 | 2兆2257億 | -4.66% |
10/30 | 3,950 | 3,952 | 3,848 | 3,855 | -3.19% | 1,252,100 | 2兆1504億 | -8.35% |
10/29 | 3,948 | 4,013 | 3,914 | 3,982 | -0.8% | 788,400 | 2兆2213億 | -5.89% |
10/28 | 4,026 | 4,044 | 4,004 | 4,014 | -0.82% | 832,900 | 2兆2391億 | -5.58% |
10/27 | 4,071 | 4,074 | 4,032 | 4,047 | -0.15% | 485,900 | 2兆2575億 | -5.22% |
10/26 | 4,073 | 4,101 | 4,042 | 4,053 | -0.42% | 316,500 | 2兆2609億 | -5.46% |
10/23 | 4,067 | 4,093 | 4,043 | 4,070 | +0.84% | 541,300 | 2兆2703億 | -5.41% |
10/22 | 4,092 | 4,095 | 4,030 | 4,036 | -2.46% | 769,500 | 2兆2514億 | -6.6% |
10/21 | 4,131 | 4,162 | 4,120 | 4,138 | +0.71% | 507,900 | 2兆3083億 | -4.72% |
10/20 | 4,111 | 4,150 | 4,099 | 4,109 | -0.58% | 642,600 | 2兆2921億 | -5.74% |
10/19 | 4,079 | 4,150 | 4,077 | 4,133 | +2.23% | 538,500 | 2兆3055億 | -5.53% |
10/16 | 4,044 | 4,062 | 4,021 | 4,043 | -0.86% | 737,100 | 2兆2553億 | -7.86% |
10/15 | 4,152 | 4,169 | 4,072 | 4,078 | -2.58% | 894,600 | 2兆2748億 | -7.44% |
10/14 | 4,177 | 4,194 | 4,151 | 4,186 | -0.21% | 694,100 | 2兆3350億 | -5.34% |
10/13 | 4,220 | 4,223 | 4,166 | 4,195 | -0.92% | 601,000 | 2兆3401億 | -5.3% |
10/12 | 4,228 | 4,265 | 4,209 | 4,234 | +0.09% | 623,400 | 2兆3618億 | -4.79% |
10/09 | 4,319 | 4,319 | 4,221 | 4,230 | -2.06% | 990,300 | 2兆3596億 | -5.24% |
10/08 | 4,343 | 4,353 | 4,317 | 4,319 | +0.28% | 689,100 | 2兆4092億 | -3.57% |
10/07 | 4,312 | 4,334 | 4,287 | 4,307 | -1.24% | 732,700 | 2兆4025億 | -4.14% |
10/06 | 4,331 | 4,366 | 4,318 | 4,361 | +1.02% | 420,600 | 2兆4327億 | -3.2% |
10/05 | 4,312 | 4,395 | 4,294 | 4,317 | +0.75% | 756,000 | 2兆4081億 | -4.43% |
10/02 | 4,426 | 4,440 | 4,270 | 4,285 | -3.66% | 1,267,100 | 2兆3903億 | -5.43% |
09/30 | 4,613 | 4,624 | 4,437 | 4,448 | -3.58% | 1,609,700 | 2兆4812億 | -2.16% |
09/29 | 4,559 | 4,636 | 4,506 | 4,613 | +0.79% | 722,900 | 2兆5732億 | +1.3% |
09/28 | 4,578 | 4,590 | 4,494 | 4,577 | +1.04% | 1,075,700 | 2兆5532億 | +0.46% |
09/25 | 15:00 抗精神病薬「エビリファイ持続性水懸筋注用」双極I型障害の効能追加が承認 |
09/25 | 4,513 | 4,543 | 4,490 | 4,530 | +1.34% | 903,600 | 2兆5269億 | -0.61% |
09/24 | 4,466 | 4,485 | 4,444 | 4,470 | -0.29% | 633,200 | 2兆4935億 | -2.1% |
09/23 | 4,450 | 4,497 | 4,436 | 4,483 | +0.09% | 832,200 | 2兆5007億 | -2.03% |